Birdwatch Note Rating
2024-11-29 02:30:19 UTC - NOT_HELPFUL
Rated by Participant: 765C80AB935AC3F69284DC4BE6A76ACCA5EAFED6C57C0F1F785C15418944126B
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details